# Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

> **NCT06309862** · — · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 15 (estimated)

## Conditions studied

- Cardio-Oncology
- Cardiomyopathy Due to Drug

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06309862
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309862, "Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06309862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*